In July 13, 2007, the company Stemmatters, a spin-off from the 3B’s Research Group – University of Minho, was awarded the National Prize for Innovation START – promoted by the Portuguese bank BPI, Microsoft and the Universidade Nova de Lisboa. Stemmatters intends to capitalize all research activity developed in the last decade by the 3B’s Research Group, one of the European and Worldwide leaders in this field of research, making the pathway to apply the new regenerative therapies to clinic. Stemmatters has as major goal the development and commercialization of new regenerative therapies for bone, cartilage and skin.